Page last updated: 2024-11-03

procarbazine and Uremia

procarbazine has been researched along with Uremia in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ellman, L1
Davis, J1
Lichtenstein, NS1

Other Studies

1 other study available for procarbazine and Uremia

ArticleYear
Uremia due to occult lymphomatous infiltration of the kidneys.
    Cancer, 1974, Volume: 33, Issue:1

    Topics: Biopsy; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Kidney Neoplasms; Mechlorethamin

1974